Published • loading... • Updated
A Single Shot May Help the Immune System Fight Hepatitis B, and the Early Results Are Raising Hopes
Summary by Earth
4 Articles
4 Articles
Hepatitis B may remain unnoticed, but it may have serious consequences for the liver. A new active substance could make long-term therapy unnecessary for some chronically ill patients.
Have you had enough of bad news? In this STANDARD column we dedicate ourselves to everything that goes well
GSK has reported results from two international phase III trials showing that its experimental drug bepirovirsen achieved functional cure rates for chronic hepatitis B of up to 26% in certain patient groups, compared to 0% with normal treatment.
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
